Real World Evidence Solutions Market Outlook Research Report, Trends, Growth and Scope By Forecast 2025 - 2032 | IQVIA HOLDINGS INC., (US) Merative (US)

Global Real World Evidence Solutions Market Size, Status, and forecast for the 2025-2032. The research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Real World Evidence Solutions Market industry, as well as predicted future growth, technological advancements, investment prospects, market economics, and financial data. Additionally, the report includes upstream and downstream analyses of key players, as well as global certainties and assurances. The report evaluates dynamic aspects such as forecast market information, Porter's Five Forces Analysis, sales estimates, wide product portfolio, market scenarios, and possibility studies.

The global real world evidence solutions market size was estimated at USD 2.7 billion in 2024 and is expected to grow at a CAGR of 8.5% from 2025 to 2032.

Updated Version of Sample Report Included:
https://www.marketdigits.com/request/sample/4208

Real World Evidence (RWE) Solutions Market Growth Factors

Most pharmaceutical, biopharmaceutical, and medical device companies continue to invest significantly in creating new medications and equipment. R&D is significant in the pharmaceutical industry. Pharmaceutical and biopharmaceutical companies are choosing fully integrated or functional outsourcing services from the early development stage to the late-stage development phase to meet the demands for drug discovery and development due to their increasing R&D expenditure. The pharmaceutical sector of the economy spends the highest proportion of its revenue on research and development. The market is expected to rise due to this increase in R&D spending, driven by the demand for numerous preclinical and clinical services during drug development.

Market Restraints

Real-world evidence has spread quickly across applications, but some stakeholders still need to learn to rely on them. For instance, although payers have begun using RWE, they prefer to use internal observational data from randomized clinical trials (RCTs) to inform drug coverage decisions. The primary justification for this preference is the availability of numerous standards and techniques for analyzing data from actual clinical experience. Additionally, there are significant differences between payers regarding the procedures and data used to determine pharmaceutical coverage. During the pharmaceutical technology assessment (PTA) process, these variations may impact patient access, reimbursement, and perhaps even healthcare outcomes across health plans. As a result, stakeholders hesitate to use evidence that was not produced using a consistent methodology.

Major Players in Real World Evidence Solutions Markets are:

IQVIA HOLDINGS INC. (US) Merative (US) Optum Inc. (US) Icon Plc. (Ireland) Syneos Health (US) Parexel International Corporation (US) ELEVANCE HEALTH INC. (US) SAS Institute Inc. (US) Aetion Inc. (US) Trinetx LLC (US) Trinity (US) PerkinElmer Inc. (US) Cognizant Technology Solutions Corporation (US) Clinigen Group plc (UK) Cegedim Health Data (France) Verantos (US) HealthVerity Inc. (US) Datavant (US) Syapse Inc. (US) Tempus (US) Flatiron Health (US) Thermo Fisher Scientific Inc. (US) Laboratory Corporation of America Holdings (US) Oracle (US)

Industry News:

In August 2023, Parexel (US) announced a strategic collaboration with Partex NV (Germany) to leverage artificial intelligence powered solutions and accelerate drug discovery and development for biopharmaceutical customers worldwide. This collaboration aims to improve outcomes for patients and create an environment of continues innovation in leveraging advanced technology, data-driven insights and collaborative ecosystem.

In June 2022, Franscisco Partners (US) acquired IBM Watson Health Business (US) and formed a new standalone company named Merative. This acquisition will help Merative in expanding reach of the healthcare data analytics products and improving healthcare delivery, decision making and performance.

In February 2022, Parexel International Corporation (US) partnered with n-Lorem Foundation (US) to improve and streamline the therapeutic development efforts of n- Lorem. This partnership will help the Parexel International Corporation in providing clinical operations, real-world data solutions, and expertise, including medical and regulatory.

"Connect with our team of research specialists and unlock the optimal solution for driving your business growth"

Global Real World Evidence Solutions Market Segmentation:

By Type:
Clinical Setting Data
Claims Data
Pharmacy Data
Patient Powered Data
Others

By Application:
Pharmaceutical and Medical Device Companies
Healthcare Payers
Healthcare Providers
Others

Know more about this report:
https://www.marketdigits.com/real-world-evidence-solutions-market-1708610489

The following areas and countries are covered in the worldwide Real World Evidence Solutions Market file:

North America (US, Canada, Mexico)
Europe (Germany, France, UK, Russia, Italy)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Saudi Arabia, UAE), Egypt, Nigeria, and South Korea)

North America is the most significant shareholder in the global market and is expected to grow remarkably during the forecast period. The region dominated a large portion of the real-world evidence solutions market in 2022, and this dominance is likely to continue over the forecast period due to rising demand for real-world evidence-based products and services, the move toward value-based care over volume-based care, and the strategies they use for their product development.

Detailed industry forecast-Brief Introduction to the research report:

Additional information on company participants
Customized reports and analyst assistance are available upon request.
Recent market developments and potential future growth opportunities
Personalized regional/country reports upon request
New data sources are being integrated.
Increased focus on data privacy and security
Increased collaboration and co-creation

Discover More: Visit Our Website for Additional Reports!

https://www.marketdigits.com/face-mask-market-1694177145

https://www.marketdigits.com/biotech-ingredients-market-1694177145

https://www.marketdigits.com/powder-coatings-market-1694177145

https://www.marketdigits.com/plastic-recycling-market-1694177146

https://www.marketdigits.com/industrial-flooring-market-1694177146

About Us

Founded in 2015, MarketDigits Consulting & Advisory Pvt Ltd is a leading business research and consulting firm. Our mission is to empower clients by identifying emerging opportunities and driving revenue growth across industries. We specialize in providing comprehensive market insights, advanced technology solutions, and actionable strategies that support operational and strategic decision-making.

With a focus on the full value chain, our expert team delivers high-quality syndicate research reports, proprietary databases, and consulting services to help clients navigate today's competitive and dynamic business environment. At MarketDigits, we use advanced analysis to uncover profitable opportunities, enabling businesses to make smart decisions and achieve sustainable success.

Contact Us:

+1 510-730-3200 | +1 276-206-2055

sales@marketdigits.com

1248 CarMia Way Richmond

VA 23235, United States

This release was published on openPR.